The discovery that selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine are present and bioaccumulate in aquatic ecosystems have spurred studies of fish serotonin transporters (SERTs) and changes in SSRI-sensitive behaviors as adverse outcomes relevant for risk assessment. Many SSRIs also act at serotonin 5-HT1A receptors. Since capitalizing on this action may improve treatments of clinical depression and other psychiatric disorders, novel multimodal drugs that agonize 5-HT1A and block SERT were introduced.
View Article and Find Full Text PDFABSTRACT The Wellness Recovery Action Plan (WRAP) is a tool used by persons living with psychiatric disabilities, which guides the development of an individualized plan of action to help achieve and/or maintain wellness and recovery. Through use of sensory-based treatment, the clients are able to explore sensory preferences and use this information when developing their plan. The WRAP and sensory-based treatment are complementary in nature and can be successfully blended to promote wellness and recovery for this population.
View Article and Find Full Text PDFZebrafish (Danio rerio) associative responses are useful for pharmaceutical and toxicology screening, behavioral genetics, and discovering neural mechanisms involved in behavioral modulation. In novel environments, zebrafish swim to tank bottoms and dark backgrounds, behaviors attributed to anxiety associated with threat of predation. To examine possible genetic effects of inbreeding and segregation on this behavior, we compared Zebrafish International Resource Center (ZIRC) AB and WIK lines to zebrafish and GloFish® from a pet store (PETCO) in two qualitatively different novel environments: the dive tank and aquatic light/dark plus maze.
View Article and Find Full Text PDF